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The Evolution of Therapy for Single Vessel Disease:
A Treatment Comparison of Medicine, Angioplasty
and Left Internal Mammary Artery Graft for Proximal
Left Anterior Descending Disease
Joseph A. Puma, Michael H. Sketch, Jr., Laura H. Gardner, Charlotte L. Nelson,
Harry R. Phillips, Richard S. Stack, Robert M. Califf. Duke University Medical Cente"
Durham. N. C.
coronary artery disease (CAD) and good left ventricular function is unclear. To
address this issue, we retrospectively analyzed 400 matched pts with three
vessel CAD and ejection fraction >40% who underwent either elective an-
gioplasty (PTCA) or bypass surgery (CABGJ. Exclusion criteria included prior
PTCA or CABG, left main CAD, evolving myocardial infarction, and chronic
total occlusions. The groups were matched for age, ejection fraction (59%
= PTCA vs 57% = CABG) and extent of CAD. Long-term follow-up was avail-
able in all pts and averaged 58 ± 25 months.
Events Medicine PTCA LIMA P-value
- unadjusted survival (%) 78 85 91 0.001
- adjusted survival (%) 84 86 90 0.24
- event-free survival (%) 54 43 72 0.0001
Conclusion: There is a trend towards improved long-term survival in prox-
imal LAD disease with a strategy of revascularization, particularly the LIMA
graft. Furthermore, event-free survival is significantly improved with the LIMA
graft as compared to medical therapy or PTCA.
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None of these comparisons is statistically significant.
Correlation Analysis·Significant Findings
Xue-Qiao Zhao, B. Greg Brown, Lynn A. Hillger, HUlman X. Barnhart, Spencer
B. King III. EASTAngiographic Core Lab, Univ. of Washington. Seattle. WA: Emory Uni~
School of Medicine. ANanta, GA
The Emory Angioplasty vs. Surgery Trial (EAST) randomized pts with multi-
vessel disease to an initial strategy of PTCA or CABG. Of 298 pts who com-
pleted 3-year angiographic follow-up (FlU). 53 (18%) had at least one new
lesion (N-Les) in their native vessels. The definitions for N-Les were: (1) per-
cent stenosis (%5) at baseline was <50%5. measured by quantitative arteri-
ography, (2) increased by at least 10%5 to become ::::50%5 during the 3-year
FlU. N-Les were located either in a non-procedure native vessel (Tp. A) or in
procedure vessel, distal to the direct effects of PTCA or CABG (Tp. B). "In-
strumented" N-Les possibly due to balloon injury and "hemdynamic" N-Les
proximal to, or at, the CABG sites were excluded from this analysis. PTCA
and CABG were compared in terms of proportion of pts with N-Les (any. Tp. A
or Tp. B) or whose N-Les caused O-wave infarction (MI), or a large reversible
thallium defect (TL). or required additional procedure(s) (AddP). and of %5 of
these N-Les at baseline (%SB) and when N-Les were first seen (%SN-Les).
The occurrence of N-Les, per pt, was correlated with 30 common risk vari-
ables.
Results:
Comparison of Frequency of N-Les between PTCA and CABG
9:45
Conclusion: In pts with three vessel CAD and ejection fractions above
40%, PTCA and CABG resulted in equivalent long-term survival and freedom
from death andlor myocardial infarction. However, recurrent revasculariza-
tion procedures were required much more frequently following PTCA.
9:30
Conclusions: There were no differences between PTCA and CABG in terms
of the frequency of N-Les, and the frequency of ischemic evidence due to
N-Les over the 3 years. Of 136 pts who completed 3-year angiographic FlU
and had MI or TL or AddP. only 19 (14%) were due to N-Les. As expected,
both PTCA and CABG pts with atherogenic risk profiles were more likely to
develop N-Les.
1738-5\ Three-year Frequency of New Lesions in Native
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Saphenous vein bypass grafting for single vessel disease offers no survival
or symptom relief advantage compared to medical therapy. Recent evidence
suggests the use of the internal mammary artery or PTCA may be more bene-
ficial than medicine. To examine the outcome of these treatment strategies, a
retrospective analysis of prospectively collected data on 23,018 consecutive
patients undergoing cardiac catheterization between April 1986 and Febru-
ary 1994 was performed. Of the 6,432 patients with single vessel disease,
1,222 had a proximal left anterior descending (LAD) stenosis> 74% and no
prior PTCA or CABG. A total of 289 were managed medically, 760 underwent
PTCA, and 172 received a left internal mammary artery (LIMA) graft.
Baseline demographic data and risk factor profiles were similar except for
a higher incidence of diabetes (19 vs 15 vs 11 %), history of MI (72 vs 58
vs 48%) CHF (18 vs 7 vs 8%). and total occlusions (44 vs 17 vs 7%) and
lower incidence of unstable angina (40 vs 61 vs 64%) in the medical group
as compared to PTCA and LIMA graft. respectively.
Kaplan-Meier 6-year estimates:
Joseph A. Puma, Michael H. Sketch, Jr., James E. Tcheng, Laura H. Gardner,
Charlotte L. Nelson, Donald F. Fortin, Harry R. Phillips, Richard S. Stack, Robert
M. Califf. Duke University Medical Cente" Durham, N.c.
While medical management of pts with single vessel chronic total occlusions
has been associated with high rates of death, MI and need for revasculariza-
tion at long-term follow-up, the role of PTCA in these pts is poorly defined.
To develop a paradigm for the comparison of medical therapy versus PTCA
in the management of chronic total occlusions, we retrospectively analyzed
prospectively-collected data on 23,005 pts undergoing cardiac catherization
between April 1986 and February 1994. Of the 6,430 pts with single-vessel
disease, 748 had a total occlusion without an acute myocardial infarction
within 30 days and no history of PTCA or CABG. A total of 611 pts were
managed medically and 137 pts underwent PTCA.
The 2 groups were similar with regard to most baseline characteristics, but
the medically-treated group had higher rates of CHF (16 vs 9%) and prior MI
(50 vs 31 %), and the PTCA cohort had more unstable angina (36 vs 20%) and
left anterior decending disease (63 vs 34%). While early mortality was simi-
lar, the 4-year mortality was statistically insignificantly higher in the medical
cohort (12 vs 7%).
Kaplan-Meier 4-year estimates:
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Long-term Survival with a Chronic Total Coronary
Occlusion: A Comparison of Medical Therapy versus
Angloplasty in Patients with Single Vessel Disease
Events
-CABG
- PTCA
-MI
Conclusion: The trend towards lower mortality in the presence of higher
non-fatal events provides a rationale for opening chronic total occlusions that
can be tested in larger prospective studies.
1738-61 Recanalization of Chronically Occluded Bypass
Grafts: The Effect of Angioplasty Site Following
Extended Urokinase Infusion on 6 Month Patency
9:15
Coronary Angioplasty versus Bypass Surgery for
Patients with Three Vessel Coronary Disease and
Ejection Fraction >40%
Siroth Charnond, James H. O'Keefe, Jr., Ben D. McCallister. Mid America Heart
Institute. f(J)nsas City, Missoud
The optimal mode of revascularization for patients (pts) with three vessel
Joseph R. Hartmann, Louis S. McKeever, William W. O'Neill, Christopher J. White,
Patrick J. Whitlow, Elaine L. Enger, ROBUST Investigators. USA
One hundred seven patients with chronically occluded aortocoronary bypass
grafts were enrolled in the ROBUST trial to determine the safety and effi-
cacyof low dose, long-term urokinase intracoronary infusions in recanalizing
these vessels. Initial patency rate was 69% and 6 month patency was 47%.
The relationship between site of angioplasty following successful lysis and
6 month graft patency was reviewed. Patients with angioplasty at the distal
anastomosis had an 88% acute patency rate vs 85% at sites within the graft.
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Six month patency was 25% for distal anastomosis and 50% for intragraft
sites. Although distal graft and distal anastomosis vs origin, proximal, or mid
graft acute patency rates were the same (85%), 6 month patency was 32%
vs 59%.
Conclusion: Chronically occluded vein grafts with culprit lesions in the
proximal or mid graft have a greater 6 month patency rate following recanal-
ization with long germ intragraft urokinase infusion than when the lesion is
in the distal graft or anastomosis.
Left Ventricular Assist Devises: Uses in
Cardiology
Tuesday, March 21,1995,8:30 a.m.-10:00 a.m.
Ernest N. Morial Convention Center, Room 64
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1739-1 I Multivessel Supported Coronary Angioplasty in
Cardiogenic Shock
Fayaz A. Shawl, Sandeep Bajaj, Alain Efstratiou, Susan B. Hoff, Kathryn
G. Dougherty. Washington Adventist Hospital, Takoma Park, Maryland
Coronary Angioplasty (CA) of the only infarct-related vessel (IRVI in pts with
multivessel (MV) Coronary Artery Disease (CAD) and Cardiogenic Shock (CS)
has been associated with a poor prognosis. No report exists on multivessel
CA in the setting of acute myocardial infarction (Mil with C.S. Eleven consec-
utive pts (ages 41-77 yrs) with MVCAD and acute MI (anterior in 9; inferior
in 2) had percutaneous cardiopulmonary bypass support (PCPS) instituted
30-240 minutes after the onset of C.S. Eight had prior MI, 4 were on balloon
pump and 4 had recent cardiac arrest. Ejection fraction (EF) ranged from 11-
40% (mean 24.7 ± 3%) and TIMI flow was diminished to grade I or II in 12 of
17 non IRVs. A mean flow rate of 4.0 Umin was achieved with mean BP 68-
85 mmHg on PCPS prior to CA, which was attempted in 28 vessels (2.5 per
ptl with angiographic success in 27 of 28 vessels. AIlIRV were successfully
dilated. Total bypass time ranged from 41-360 min (mean 138 ± 72 min).
Four pts died post CA: 2 due to acute closure of IRV, 1 due to CVA and 1
due to sepsis. All 7 survivors are alive at a mean follow-up of 24 ± 6 months,
with EF increased to mean 38 ± 5% (p < 0.051. Five pts are functional class
I and have required no interventions. Two other pts have required repeat
interventions for restenosis. Conclusion: PCPS can stabilize pts in CS and
facilitate MVCA which may result in improved survival.
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1739-21 Intraaortic Balloon Pumping Augments Distal
Coronary Blood Flow Provided Through Perfusion
Balloon Catheters During High Risk PTCA
Richard G. Bach, Thomas J. Donohue, Eugene A. Caracciolo, Frank V Aguirre,
Thomas Wolford, Morton J. Kern. St. Louis University Medical Center. St Louis, MO
Perfusion balloon catheters (PBC) utilized for PTCA deliver antegrade distal
blood flow during balloon inflation, limiting ischemia and permitting poten-
tially hazardous or prolonged dilatations useful in management of high risk
procedures. Distal flow is passive via the catheter lumen and determined in
part by perfusion pressure, which may limit distal blood flow delivery, espe-
cially with lower profile PBC. Intraaortic balloon pumping (IABP) has been
shown to increase diastolic pressure and blood flow in non-stenosed coro-
nary arteries. To quantitate whether distal blood flow delivery via PBC could
be augmented using intraaortic balloon pumping (IABP), we measured dis-
tal coronary flow velocity using an 0.018" Doppler-tipped guidewire placed
alongside an inflated PBC (Flowtrack 40; ACS, Inc) during PTCA in 5 patients
(4 LAD, 1 LCX) during high risk PTCA. Distal average peak velocity (APV, cm/s).
systolic peak velocity (SPV, cm/s) and diastolic peak velocity(DPV, cm/s)were
quantitated and volumetric coronary blood flow (CBF, mllminl derived (APV
x 0.5 x distal angiographic cross sectional area x 60) during PBC inflation
without and with IABP. Results (means ± SD):
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1739-31 Utility of Standby CPS for Elective Coronary
Intervention
Erminia M. Guarneri, Richard A. Schatz, Donald E. Shows, Theodore Spinks, Nancy
B. Morris, Paul S. Teirstein. Scripps Clinic and Research Foundation, La Jolla, CA
At Scripps Clinic, elective PTCA is performed without formal surgical
"backup." Instead, a policy of "standby cardiopulmonary support (CPS)" and
"next available operating room" is used for all patients. Standby CPS is de-
fined as a perfusionist physically present at and dedicated to the catheter-
ization laboratory with immediate access, to the CPS apparatus. Standby
CPS is required for all patients undergoing elective coronary intervention.
Between January 1989 and June 1994 we performed a total of 2,850 elec-
tive coronary intervention procedures. Eleven patients required initiation of
emergency CPS. The mean ejection fraction of this group was 50%. Causes
of patient decompensation included no reflow (28%), abrupt closure (28%).
refractory pulmonary edema (18%), LM dissection (18%), and target vessel
perforation (9%). All patients required endotracheal intubation and CPR prior
to CPS insertion. Two patients who sustained LM dissection and one patient
with an LAD perforation were sustained on CPS for ±60 minutes until an
operating room became available. The other 8 (73%) patients went on to
complete their coronary interventional procedure while on CPS. A total of 15
lesions in 8 patients were treated; 4 patients required bailout stents.
AI18 patients who completed their interventional procedures were weaned
from CPS in the cardiac cath lab. CPS cannulas were removed under direct
vessel visualization in 64%. One patient sustained a femoral artery lacera-
tion warranting surgical repair and one developed a femoral artery pseudoa-
neurysm. All patients required blood transfusions secondary to groin bleed-
ing. Two patients (18%) died following CABG surgery and the remaining 9
patients sustained non-Q-wave myocardial infarctions.
Conclusion: Standby CPS can decrease mortality in patients who sus-
tain cardiovascular collapse during elective coronary intervention and should
not be limited solely to patients with poor ventricular function or high-risk
anatomy.
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Left Ventricular Systolic Dysfunction may Precede
Diastolic Dysfunction by Intervention of
Extracorporeal Circulation
Akira Seki, Michlo Sasaki, Hiroshi Masumoto, Hitoshi Ishihara 1,
Mitsuhiro Yokota 1. Department of Cardiovascular Surgery, Okazaki City Hospital,
Okazaki; Japan; 1 Department of Clinical Laboratory Medicine, Nagoya University School
ofMedicine, Nagoya, Japan
The aim of this study was to investigate the influence of extracorporeal circu-
lation during cardiac surgery on left ventricular contractile and diastolic func-
tion by means of pressure volume relationship. Study population was 12 pa-
tients received cardiac surgery (LVEF exceeded 50% without localized asyn-
ergy left ventricle). We measured the end-systolic and end-diastolic pressure-
volume relationship by using conductance catheter with micromanometer
tip which was inserted through left atrium into left ventricle. End-systolic
elastance (Ees), peak positive dp/dt (+dp/dt max). time constant of isovolu-
mic pressure decay (TL:Weiss and TD:Raff and Glantz). and stiffness con-
stant k of end-diastolic pressure-volume relationship were obtained before
and after extracorporeal circulation. The end-diastolic pressure-volume rela-
tionship was well fit by exponential curve (r = 0.95 ± 0.28, P < 0.001).
Ees decreased from 2.10 ± 0.85 to 1.34 ± 0.75 mmHg/ml (p < 0.05).
+dp/dt max showed no significant tendency in change, because of the con-
siderable change in loading condition. TL and TD did not change significantly.
End-diastolic pressure-volume relationships moved on the same exponential
fitting curve, and k remained unchanged (0.019 ± 0.005 to 0.021 ± 0.006,
n.s.) before and after extracorporeal circulation.
In conclusion, extracorporeal circulation decreased left ventricularcontrac-
tility, but had no significant influence either active or passive phases of left
ventricular diastolic function. This fact suggested that left ventricular systolic
dysfunction may precede diastolic dysfunction by intervention of extracorpo-
real circulation.
While not affecting SPV, IABP increased APV, DPV and CBF measured dis-
tal to the inflated PBC by means of 22%, 35% and 22%, respectively. We
conclude that use of IABP can significantly augment distal blood flow de-
livery by PBC during PTCA. This augmented distal perfusion may provide a
mechanism to further reduce ischemia and increase the safety of high risk
PTCA.
IABP OFF
IABP ON
p value
APV SPV DPV Distal CBF
10.1 ± 3 8.1 ± 2 15.5 ± 7 157 ± 6
123 ± 4 7.6 ± 3 203 ± 7 190 ± 7
0.01 0.46 0001 0.009
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1739-51 Assessment of the Immediate Effects of Mechanical
Left Ventricular Assistance on Right Ventricular
Performance by Automated Pressure-Area Relations
Robert L. Kormos, William A. Mandarino, Thomas A. Gasior, Bartley P Griffith,
John Gorcsan III. University of Pittsburgh. Pittsburgh. PA
Right ventricular (RV) performance is important for global cardiac function
in pts with severe heart failure. The use of a mechanical LV assistance de-
vice (LVAD) may be life-saving in these pts. However, the physiological ef-
